Nonsteroidal antiinflammatory drugs: new alternatives for rheumatic disease.
New antirheumatic drugs which are moderately effective clinically and less toxic than similarly acting, previously available drugs are believed to act by blocking certain mediators of inflammation. At present, there is no evidence that they influence the release of lysosomes, inhibit the action of complement, or modify immune mechanisms.
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005279:Fenoprofen / Q000627:therapeutic use*; D006801:Humans; D007052:Ibuprofen / Q000627:therapeutic use*; D009288:Naproxen / Q000627:therapeutic use*; D010666:Phenylpropionates / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use*; D014046:Tolmetin / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D010666:Phenylpropionates; D011758:Pyrroles; D009288:Naproxen; D014046:Tolmetin; D005279:Fenoprofen; D007052:Ibuprofen